Advertisement

Reactions Weekly

, Volume 1753, Issue 1, pp 95–95 | Cite as

Carfilzomib/dexamethasone/rituximab

Various toxicities: 6 case reports
Case report
  • 28 Downloads

Reference

  1. Chaudhry M, et al. Carfilzomib-based combination regimens are highly effective frontline therapies for multiple myeloma and Waldenstrom's macroglobulinemia. Leukemia and Lymphoma 60: 964-970, No. 4, 21 Mar 2019. Available from: URL: http://doi.org/10.1080/10428194.2018.1508668 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations